Sara L. Shepheard
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)MSD (UK) Limited (United Kingdom)(GB)
Publications by Year
Research Areas
Migraine and Headache Studies, Neuropeptides and Animal Physiology, Pharmacological Receptor Mechanisms and Effects, Receptor Mechanisms and Signaling, Neuroscience of respiration and sleep
Most-Cited Works
- → Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats(1995)168 cited
- → The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation(1997)141 cited
- → Possible Antimigraine Mechanisms of Action of the 5HT1F Receptor Agonist LY334370(1999)113 cited
- → The non‐peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats(1993)104 cited
- → The anti‐migraine 5‐HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea‐pigs(2001)71 cited
- → A gamma‐aminobutyric‐acid‐mediated inhibition of neurones in the nucleus tractus solitarius of the cat.(1987)70 cited